Literature DB >> 3463508

Activity of newer antimicrobial agents against Aeromonas hydrophila.

K V Rolston, D H Ho, B LeBlanc, G P Bodey.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3463508     DOI： 10.1007/BF02075707

Source DB:  PubMed          Journal:  Eur J Clin Microbiol        ISSN： 0722-2211            Impact factor:   3.267


× No keyword cloud information.
  9 in total

1.  In-vitro activity of cefpirome (HR-810), WIN-49375, BMY-28142 and other antibiotics against nosocomially important isolates from cancer patients.

Authors:  K V Rolston; M E Alvarez; K C Hsu; G P Bodey
Journal:  J Antimicrob Chemother       Date:  1986-04       Impact factor: 5.790

2.  In vitro susceptibilities of Aeromonas hydrophila to 32 antimicrobial agents.

Authors:  R J Fass; J Barnishan
Journal:  Antimicrob Agents Chemother       Date:  1981-02       Impact factor: 5.191

3.  In vitro susceptibilities of Aeromonas hydrophila against new antibiotics.

Authors:  V Fainstein; S Weaver; G P Bodey
Journal:  Antimicrob Agents Chemother       Date:  1982-09       Impact factor: 5.191

4.  Comparative in vitro activities of selected antimicrobial agents against Aeromonas species and Plesiomonas shigelloides.

Authors:  J F Reinhardt; W L George
Journal:  Antimicrob Agents Chemother       Date:  1985-04       Impact factor: 5.191

5.  Bacteremia caused by Aeromonas species in hospitalized cancer patients.

Authors:  R L Harris; V Fainstein; L Elting; R L Hopfer; G P Bodey
Journal:  Rev Infect Dis       Date:  1985 May-Jun

6.  Antibiotics in patients with neutropenia.

Authors:  G P Bodey
Journal:  Arch Intern Med       Date:  1984-09

7.  In vitro susceptibilities of Aeromonas hydrophila, Aeromonas sobria, and Aeromonas caviae to 22 antimicrobial agents.

Authors:  M R Motyl; G McKinley; J M Janda
Journal:  Antimicrob Agents Chemother       Date:  1985-07       Impact factor: 5.191

8.  Diarrhea due to Plesiomonas shigelloides in cancer patients.

Authors:  K V Rolston; R L Hopfer
Journal:  J Clin Microbiol       Date:  1984-09       Impact factor: 5.948

9.  In vitro activities of the quinolone antimicrobial agents A-56619 and A-56620.

Authors:  G M Eliopoulos; A E Moellering; E Reiszner; R C Moellering
Journal:  Antimicrob Agents Chemother       Date:  1985-10       Impact factor: 5.191
  9 in total
  4 in total

1.  In vitro activity of various new antimicrobial agents against group JK corynebacteria.

Authors:  K V Rolston; G P Bodey
Journal:  Eur J Clin Microbiol       Date:  1987-08       Impact factor: 3.267

Review 2.  Cefepime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  L B Barradell; H M Bryson
Journal:  Drugs       Date:  1994-03       Impact factor: 9.546

Review 3.  Fluoroquinolone antimicrobial agents.

Authors:  J S Wolfson; D C Hooper
Journal:  Clin Microbiol Rev       Date:  1989-10       Impact factor: 26.132

4.  Leech therapy for epidermoid cysts and review of the literature.

Authors:  Abbas Rasi; Alireza Faghihi; Mirhadi Aziz Jalali; Abbas Zamanian; Gholamhossein Ghaffarpour
Journal:  Adv Biomed Res       Date:  2014-03-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.